Henriksen Kim

Biography

Kim Henriksen joined Nordic Bioscience in 2002 and assumed the position as Head of Muscoloskeletal Diseases 2011. Kim’s research has focused primarily on three areas; i) the development of novel therapeutic peptides for the indications: type 2-diabetes, obesity and NASH, which has research has resulted in several peptide candidates in preclinical development and 1 in clinical testing and ii) the potential of protein fragments as biomarkers of both musculoskeletal diseases and, more recently, neurodegenerative diseases, which has resulted in assays measuring degradation of tau in blood, which are being explored for their prognostic ability within dementias. During his scientific career Kim has published more than 130 peer-reviewed articles and given numerous oral presentations at international meetings. Kim has an H-factor of 34 (JUNE 2017).

Research Interest

Pharmaceutical Sciences